Overview

Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the additional effect of probucol or concomitant administration of cilostazol and probucol on mean carotid artery intima-media thickness (mean IMT) at year 1, 2, and 3.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Korea Otsuka Pharmaceutical Co., Ltd.
Treatments:
Cilostazol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Probucol